Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$276M |
| 2 |
IBM
IBM
|
+$272M |
| 3 |
Procter & Gamble
PG
|
+$161M |
| 4 |
Colgate-Palmolive
CL
|
+$151M |
| 5 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$405M |
| 2 |
CELG
Celgene Corp
CELG
|
+$207M |
| 3 |
Booking.com
BKNG
|
+$123M |
| 4 |
Eli Lilly
LLY
|
+$114M |
| 5 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.92% |
| 2 | Healthcare | 13.46% |
| 3 | Consumer Discretionary | 11.99% |
| 4 | Industrials | 10.52% |
| 5 | Consumer Staples | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Seaboard Corp
SEB
$4.08B
| $14.8M | 0.03% |
4,885
-742
| -13% | -$1.99M |
|
627
Royal Gold
RGLD
$19.1B
| $14.7M | 0.03% |
193,709
+188,009
| +3,298% | +$12.4M |
|
628
Spire
SR
$4.9B
| $14.7M | 0.03% |
303,700
+259,131
| +581% | +$12.1M |
|
629
Ericsson
ERIC
$33.6B
| $14.7M | 0.03% |
1,217,700
-1,536,001
| -56% | -$19.1M |
|
|
WCC
630
WESCO International
WCC
$17.5B
| $14.7M | 0.03% |
170,000
+56,783
| +50% | +$4.96M |
|
|
TMH
631
DELISTED
Team Health Holdings Inc
TMH
| $14.6M | 0.03% |
292,600
+13,581
| +5% | +$657K |
|
|
CMLP
632
DELISTED
CRESTWOOD MIDSTREAM PARTNERS LP NEW UTS REP LTD PRT INT (DE)
CMLP
| $14.6M | 0.03% |
660,790
+333,404
| +102% | +$7.46M |
|
633
CoStar Group
CSGP
$13.4B
| $14.6M | 0.03% |
919,980
-585,980
| -39% | -$9.49M |
|
|
PIR
634
DELISTED
Pier 1 Imports, Inc.
PIR
| $14.5M | 0.03% |
+47,065
| New | +$16.5M |
|
|
CVD
635
DELISTED
COVANCE INC.
CVD
| $14.5M | 0.03% |
169,100
-19,918
| -11% | -$1.77M |
|
|
PES
636
DELISTED
Pioneer Energy Services Corp.
PES
| $14.5M | 0.03% |
824,898
+586,820
| +246% | +$8.8M |
|
|
ALE
637
DELISTED
Allete
ALE
| $14.4M | 0.03% |
280,999
+207,769
| +284% | +$10.4M |
|
638
Lincoln Electric
LECO
$15.5B
| $14.4M | 0.03% |
206,238
+24,150
| +13% | +$1.64M |
|
639
Argan
AGX
$7.84B
| $14.4M | 0.03% |
385,600
+93,700
| +32% | +$2.81M |
|
640
Lockheed Martin
LMT
$138B
| $14.4M | 0.03% |
+89,300
| New | +$14.5M |
|
|
VIVO
641
DELISTED
Meridian Bioscience Inc
VIVO
| $14.3M | 0.03% |
695,276
+164,200
| +31% | +$3.37M |
|
642
MBIA
MBI
$262M
| $14.3M | 0.03% |
1,299,200
+734,362
| +130% | +$9.05M |
|
|
ADAM
643
Adamas Trust
ADAM
$907M
| $14.3M | 0.03% |
458,125
-53,000
| -10% | -$1.63M |
|
644
Lattice Semiconductor
LSCC
$18.2B
| $14.3M | 0.03% |
1,734,301
+412,146
| +31% | +$3.33M |
|
|
AHL
645
DELISTED
ASPEN Insurance Holding Limited
AHL
| $14.2M | 0.03% |
311,700
+202,230
| +185% | +$9.06M |
|
|
TIBX
646
DELISTED
TIBCO SOFTWARE INC
TIBX
| $14.1M | 0.03% |
699,165
-364,373
| -34% | -$7.27M |
|
647
Centene
CNC
$32.6B
| $14.1M | 0.03% |
745,600
-48,880
| -6% | -$840K |
|
648
Extreme Networks
EXTR
$3.16B
| $14.1M | 0.03% |
3,173,077
-558,100
| -15% | -$2.63M |
|
|
NILE
649
DELISTED
Blue Nile, Inc.
NILE
| $14M | 0.03% |
501,312
+227,691
| +83% | +$7.17M |
|
|
TIS
650
DELISTED
Orchids Paper Products, Inc.
TIS
| $14M | 0.03% |
436,800
+36,900
| +9% | +$1.09M |
|
Similar funds
Jim Simons's Q2 2014 Portfolio in Review
As of Q2 2014, Jim Simons held 3,246 positions worth $42.9B, up 2.9% from $41.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons's Q2 2014 filing shows 450 new, 1,273 increased, 1,008 reduced and 492 closed positions. Its largest new stake was Procter & Gamble: 2,001,729 shares worth $157M. The largest sale was Verizon, an estimated $405M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2014 buy was Procter & Gamble: 2,001,729 shares worth $157M.
- Jim Simons added most to Pfizer in Q2 2014, an estimated $276M increase.
- Jim Simons's biggest Q2 2014 reduction was Verizon, cutting an estimated $405M.
- Jim Simons fully exited Booking.com in Q2 2014, selling an estimated $123M.
- Jim Simons's ten largest holdings make up 14% of its $42.9B portfolio in Q2 2014.
- Jim Simons opened 450 new positions and closed 492 in Q2 2014.
- Jim Simons's portfolio value rose 2.9% quarter-over-quarter to $42.9B.
Based on Renaissance Technologies's 13F filing for Q2 2014, filed 13 Aug 2014.